Higher standards in healthcare call for a higher standard of therapy. Now you can take post-operative care to new levels and provide your patients with protection from post-surgical complications with closed incision negative pressure therapy (ciNPT).
In an increasingly complex healthcare environment, surgeons are faced with unique challenges that can negatively affect outcomes. Eﬀectively managing the risk of postoperative complication is a priority.
In a newly published 2023 Multi-Specialty Meta-Analysis, Prevena Therapy has demonstrated signiﬁcant improvement in key patient outcomes across multiple specialties.5
Proactive Risk Management (PRM) with Prevena Therapy provides healthcare professionals with an evidence-based, standardized approach that helps to advance the standard of care for ciNPT. This intuitive, actionable model is grounded in level 1, 2 and 3 clinical evidence to help support you through procedural and patient risk stratiﬁcation.
An error has occurred while submitting. Please try again later...
Your form was submitted successfully
The brands listed above are trademarks of 3M.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at hcbgregulatory.3m.com/
1. Zimlichman E, Henderson D, Tamir, et al. Health care-associated Infections a meta-analysis of costs and ﬁnancial impact on the U.S. health care system. JAMA Interned.2013;173(22):20-46.
2. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated Infections. N Engl JMed: 2014;370:1198-208.
3. Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals. The hospital management perspective. JAMA Surg. 2013;148(10):907-914.doi:10.1001/jamasurg.2013.2246 Published online August 21, 2013.
4. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874.
5. Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griﬃn L. Closed Incision Negative Pressure Therapy Versus Standard of Care Over Closed Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-Analysis of Comparative Studies. Plastic and Reconstructive Surgery – Global Open. 2023 Mar 16;11(3):e4722.